The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · National Taiwan University Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases, Neutropenia and Nudt15 Deficiency. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 1 to 25
- Any sex
Some of the main requirements, copied from the record:
- Participants who are diagnosed with inflammatory bowel disease.
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 65 participants are expected to take part.
- Start date: 2023-12-27.
- Main results expected around 2026-01 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Taiwan.
Main thing being measured
- Neutropenia (2 years)
In the researchers’ words
The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases; Neutropenia; Nudt15 Deficiency |
| Lead sponsor | National Taiwan University Hospital |
| Enrollment | 65 (estimated) |
| Start date | 2023-12-27 |
| Primary completion (est.) | 2026-01 |
| First posted | 2025-04-06 |
| Last updated | 2025-04-08 |
| Official title | The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT06913998 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Participants who are diagnosed with inflammatory bowel disease. Exclusion Criteria: * Participants who refused to have blood test for NUDT15 gene evaluation.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital | Taipei | Taiwan | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.